Incyte to Present at the Canaccord Genuity 33rd Annual Growth Conference
Incyte to Present at the Canaccord Genuity 33rdAnnual Growth Conference
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (NAS: INCY) announced today it will present at the Canaccord Genuity 33rd Annual Growth Conference on Wednesday, August 14 at 10:30 a.m. (EDT) in Boston.
The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944
KEYWORDS: United States North America Delaware Massachusetts
INDUSTRY KEYWORDS:
The article Incyte to Present at the Canaccord Genuity 33rd Annual Growth Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
